Farzan elected to the American Academy of Microbiology
January 31, 2019
JUPITER, FL — The American Society for Microbiology has elected Scripps Research Professor Michael Farzan, PhD, to its American Academy of Microbiology. The academy’s members are elected based on their record of scientific excellence and originality, scholarly achievement, leadership and high ethical standards. Fellows represent all subspecialties of the microbial sciences, including basic and applied research, teaching, public health, industry and government service.
Farzan, based at the Jupiter, Florida Scripps Research campus, co-chairs the bicoastal institute’s Department of Immunology and Microbiology. His research focuses on immune responses to enveloped viruses including HIV-1. Farzan’s lab conducts both basic and applied research, including investigating immune responses to viral entry, and developing gene therapy strategies for universal protection from HIV-1.
The American Academy of Microbiology is the honorific leadership group within the American Society for Microbiology, among the world’s oldest and largest life science organizations. Composed of more than 30,000 scientists and health professionals, ASM promotes and advances the microbial sciences through conferences, publications, certifications and educational opportunities.
Calibr-Skaggs advances CLF065, a regenerative GLP-2 therapy, into two Phase 2 IBD studies
CLF065, a long-acting, once-weekly GLP-2 receptor agonist, advances in two inflammatory bowel disease indications. The studies aim to bring a regenerative treatment option to patients living with IBD, who currently have few therapies that repair the damaged intestinal lining at the root of their disease.